ASIA-PACIFIC MEDICAL COLLAGEN MARKET 2022-2028

 

 

TABLE OF CONTENTS   

1.     ASIA-PACIFIC MEDICAL COLLAGEN MARKET – SUMMARY

2.     INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON THE MEDICAL COLLAGEN INDUSTRY

2.2. KEY INSIGHTS

2.2.1.    SIGNIFICANT INVESTMENT IN RESEARCH AND DEVELOPMENT ACTIVITIES

2.2.2.    EVOLVING HEALTHCARE INDUSTRY

2.2.3.    LAUNCH OF NEW PRODUCTS DUE TO INCREASED RESEARCH

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1.    THREAT OF NEW ENTRANTS

2.3.2.    THREAT OF SUBSTITUTES

2.3.3.    BARGAINING POWER OF BUYERS

2.3.4.    BARGAINING POWER OF SUPPLIERS

2.3.5.    THREAT OF COMPETITIVE RIVALRY

2.4. KEY IMPACT ANALYSIS

2.4.1.    QUALITY

2.4.2.    SIDE-EFFECTS

2.4.3.    PRODUCT EFFECTIVENESS

2.4.4.    PRICE

2.5. MARKET ATTRACTIVENESS INDEX

2.6. VENDOR SCORECARD

2.7. INDUSTRY COMPONENTS

2.8. REGULATORY FRAMEWORK

2.9. KEY MARKET STRATEGIES

2.9.1.    ACQUISITIONS

2.9.2.    PRODUCT LAUNCHES

2.9.3.    PARTNERSHIPS

2.9.4.    BUSINESS EXPANSIONS

2.10.               MARKET DRIVERS

2.10.1.                    INCREASING DEMAND FROM THE MEDICAL DEVICES INDUSTRY

2.10.2.                    GROWING PUBLIC AWARENESS        

2.11.               MARKET CHALLENGES

2.11.1.                    HEALTH-RELATED ISSUES

2.11.2.                    CONSUMERS LIMITING THE USE OF ANIMAL-BASED PRODUCTS    

2.12.               MARKET OPPORTUNITIES

2.12.1.                    GROWTH OF THE COSMETICS INDUSTRY

2.12.2.                    RISING DEMAND FOR COLLAGEN-RICH FOOD & BEVERAGES  

3.     ASIA-PACIFIC MEDICAL COLLAGEN MARKET OUTLOOK – BY SOURCE

3.1. BOVINE

3.2. PORCINE

3.3. OTHER SOURCES

4.     ASIA-PACIFIC MEDICAL COLLAGEN MARKET OUTLOOK – BY PRODUCT

4.1. GELATINE

4.2. HYDROLYZED COLLAGEN

4.3. NATIVE COLLAGEN

4.4. OTHER PRODUCTS

5.     ASIA-PACIFIC MEDICAL COLLAGEN MARKET OUTLOOK – BY APPLICATION

5.1. WOUND CARE

5.2. BONE GRAFTS

5.3. TISSUE SCAFFOLDS

5.4. CARTILAGE REPAIR

5.5. HEMOSTATS

5.6. DIAGNOSTICS

5.7. VASCULAR GRAFTS

5.8. OTHER APPLICATIONS

6.     ASIA-PACIFIC MEDICAL COLLAGEN MARKET – COUNTRY OUTLOOK

6.1. CHINA

6.2. JAPAN

6.3. INDIA

6.4. SOUTH KOREA

6.5. ASEAN COUNTRIES

6.6. AUSTRALIA & NEW ZEALAND

6.7. REST OF ASIA-PACIFIC

7.     COMPETITIVE LANDSCAPE

7.1. GELITA

7.2. NITTA GELATIN INC

7.3. NIPPI INC

7.4. ITALGEL

7.5. WEISHARDT

7.6. DARLING INGREDIENTS INC

7.7. LAPI GELATINE

7.8. TESSENDERLO GROUP

7.9. DSM

7.10.               COLLAGEN MATRIX INC

7.11.               CONNOILS LLC

7.12.               INTEGRA LIFE SCIENCES

7.13.               SYMATESE

7.14.               STRYKER

7.15.               JELLAGEN

8.     RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.2. SOURCES OF DATA

8.3. RESEARCH METHODOLOGY

 

 

TABLE LIST

TABLE 1: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

TABLE 2: VENDOR SCORECARD

TABLE 3: REGULATORY FRAMEWORK

TABLE 4: LIST OF ACQUISITIONS

TABLE 5: LIST OF PRODUCT LAUNCHES

TABLE 6: LIST OF PARTNERSHIPS

TABLE 7: LIST OF BUSINESS EXPANSIONS

TABLE 8: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY SOURCE, 2022-2028 (IN $ MILLION)

TABLE 9: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY PRODUCT, 2022-2028 (IN $ MILLION)

TABLE 10: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)

TABLE 11: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

 

 

FIGURE LIST

FIGURE 1: KEY BUYING IMPACT ANALYSIS

FIGURE 2: MARKET ATTRACTIVENESS INDEX

FIGURE 3: INDUSTRY COMPONENTS

FIGURE 4: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY SOURCE, 2021 & 2028 (IN %)

FIGURE 5: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY BOVINE, 2022-2028 (IN $ MILLION)

FIGURE 6: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY PORCINE, 2022-2028 (IN $ MILLION)

FIGURE 7: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY OTHER SOURCES, 2022-2028 (IN $ MILLION)

FIGURE 8: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY PRODUCT, 2021 & 2028 (IN %)

FIGURE 9: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY GELATINE, 2022-2028 (IN $ MILLION)

FIGURE 10: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY HYDROLYZED COLLAGEN, 2022-2028 (IN $ MILLION)

FIGURE 11: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY NATIVE COLLAGEN, 2022-2028 (IN $ MILLION)

FIGURE 12: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY OTHER PRODUCTS, 2022-2028 (IN $ MILLION)

FIGURE 13: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY APPLICATION, 2021 & 2028 (IN %)

FIGURE 14: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY WOUND CARE, 2022-2028 (IN $ MILLION)

FIGURE 15: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY BONE GRAFTS, 2022-2028 (IN $ MILLION)

FIGURE 16: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY TISSUE SCAFFOLDS, 2022-2028 (IN $ MILLION)

FIGURE 17: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY CARTILAGE REPAIR, 2022-2028 (IN $ MILLION)

FIGURE 18: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY HAMOSTATS, 2022-2028 (IN $ MILLION)

FIGURE 19: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY DIAGNOSTICS, 2022-2028 (IN $ MILLION)

FIGURE 20: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY VASCULAR GRAFTS, 2022-2028 (IN $ MILLION)

FIGURE 21: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY OTHER APPLICATIONS, 2022-2028 (IN $ MILLION)

FIGURE 22: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)

FIGURE 23: CHINA MEDICAL COLLAGEN MARKET 2022-2028 (IN $ MILLION)

FIGURE 24: JAPAN MEDICAL COLLAGEN MARKET 2022-2028 (IN $ MILLION)

FIGURE 25: INDIA MEDICAL COLLAGEN MARKET 2022-2028 (IN $ MILLION)

FIGURE 26: SOUTH KOREA MEDICAL COLLAGEN MARKET 2022-2028 (IN $ MILLION)

FIGURE 27: ASEAN COUNTRIES MEDICAL COLLAGEN MARKET 2022-2028 (IN $ MILLION)

FIGURE 28: AUSTRALIA & NEW ZEALAND MEDICAL COLLAGEN MARKET 2022-2028 (IN $ MILLION)

FIGURE 29: REST OF ASIA-PACIFIC MEDICAL COLLAGEN MARKET 2022-2028 (IN $ MILLION)

 

 

MARKET OUTLOOK

A report by Triton Market Research depicts that the medical collagen market in the Asia-Pacific would progress with a CAGR of 7.23% over the forecast years from 2022 to 2028. China, India, ASEAN countries, Japan, Australia & New Zealand, South Korea, and Rest of Asia-Pacific together form the market in this region.

South Korea is witnessing a high demand for medical collagen and its market is expected to grow profoundly by the end of the forecast period. The growing acceptance by consumers for collagen products has paved the way for companies to launch new beauty products, foods, beverages, etc., in the market. In November 2021, Maypharm Co Ltd announced the launch of its new product, a PLA filler, in the market. Called MENNUS, it promotes collagen synthesis, and thus helps reduce wrinkles.

New Zealand also offers a vast growth potential to the collagen market and the companies operating in it. Marine-based collagen is extremely popular among consumers. Brands such as Dose & Co, offer a range of collagen-based products such as collagen peptides, collagen powder, and others.

Collagen products are also becoming extremely popular in the ASEAN country of Taiwan, owing to the growing consumer inclination towards beauty products. In August 2021, Maxigen Biotech Inc launched a collagen product called MAXI Collagen in the Taiwanese market. Prepared using double enzyme hydrolysis, it is highly beneficial for the skin.

 

Get more Insights into the Asia-Pacific Medical Collagen Market:

https://www.tritonmarketresearch.com/reports/asia-pacific-medical-collagen-market

 

COMPETITIVE OUTLOOK

The prominent companies in the medical collagen market are Symatese, DSM, Jellagen, Lapi Gelatine, Italgel, Stryker, Integra Life Sciences, and Darling Ingredients Inc.

 

 

 

 

SEGMENTATION

1.     GELITA

2.     NITTA GELATIN INC

3.     NIPPI INC

4.     ITALGEL

5.     WEISHARDT

6.     DARLING INGREDIENTS INC

7.     LAPI GELATINE

8.     TESSENDERLO GROUP

9.     DSM

10. COLLAGEN MATRIX INC

11. CONNOILS LLC

12. INTEGRA LIFE SCIENCES

13. SYMATESE

14. STRYKER

15. JELLAGEN